- ?? A unique product in a $37B global sexual health and wellness market
- ?? Revenue projected to reach $25M by 2025 (not guaranteed)
- ??First significant innovation in the male sexual health industry since the launch of Viagra in 1998
- ?? Pioneering sexual health company using innovative patented technology
Morari has developed a chemical-free wearable skin patch for the treatment of premature ejaculation (PE). PE is the most prevalent male sexual dysfunction, estimated to affect 30% of men worldwide.
In 5 years, we plan to have successfully launched the product in both the US and Europe and be generating revenue greater than $20 million per year. These results will make Morari an attractive acquisition target for strategic buyers.